17 Jun 2025 | Amsterdam | 08:30 AM - 10:00 AM CEST
Unlocking Value: Building a Business Case for Digital Health in Injectable Therapies
In Partnership with:Ypsomed
About this Meeting
Exploring what drives success in device-enabled digital health solutions.
This strategic roundtable equips cross-functional pharmaceutical leadership with actionable frameworks for developing comprehensive business cases and evidence generation strategies for connected injectable therapies. Through detailed case study analysis and practical implementation guidance, this roundtable provides tools to establish cross-functional consensus, drive organizational alignment, and create unified approaches to connected therapy development that demonstrate clear value to patients, providers, and payers. Participants will explore how to transform digital solutions from competitive differentiators to essential components of therapeutic offerings through robust planning and evidence-based decision making. Key discussion points will include:
Learning lessons from Merck KGaA’s successful growth hormone program
Examining and prioritizing the different levers of a compelling business case for device-enabled digital health solutions
Identifying the metrics and evidence that matter most for the digital health business case, including clinical outcomes, adherence and persistence to therapy, healthcare provider and patient preferences, and real-world data generation